Grace Therapeutics GRCE
NASDAQ GRCE
$2.14 +0.03 (+1.51%)
As of: Sep 30, 2026 · 12:18 PM EDT

Grace Therapeutics, Inc. (GRCE) Tax Provisions (2022 - 2026)

Updated

Grace Therapeutics (GRCE) posted Tax Provisions of -$1.7 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with -$1.02 million a year earlier.

Analysis

Grace Therapeutics, Inc. (GRCE) Tax Provisions (2022 - 2026) Analysis & Trends

Since fiscal Q4 2022, Grace Therapeutics has reported Tax Provisions for 14 quarters.

  • In prior fiscal years, Grace Therapeutics' Tax Provisions was -$3.2 million in FY2025, -$1.83 million in FY2024, -$9.54 million in FY2023 and -$648,000 in FY2022.
  • The fiscal Q4 2026 figure stands as the lowest quarterly Tax Provisions since fiscal Q4 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.70 Mn
Mar 31, 2025 -1.02 Mn
Dec 31, 2024 -605,000.00
Sep 30, 2024 -852,000.00
Jun 30, 2024 -724,000.00
Mar 31, 2024 -889,000.00
Dec 31, 2023 -208,000.00
Sep 30, 2023 -446,000.00
Jun 30, 2023 -289,000.00
Mar 31, 2023 -8.87 Mn
Dec 31, 2022 -274,000.00
Sep 30, 2022 -155,000.00
Jun 30, 2022 -242,000.00
Mar 31, 2022 -648,000.00
API Access

Grace Therapeutics, Inc. Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=GRCE&period=max&api_key=YOUR_API_KEY